Type
1.
Phetsuksiri B, Srisungngam S, Rudeeaneksin J, Bunchoo S, Lukebua A, Wongtrungkapun R, et al. SNP genotypes of Mycobacterium leprae isolates in Thailand and their combination with rpoT and TTC genotyping for analysis of leprosy distribution and transmission. Japanese journal of infectious diseases [Internet]. 2012;65(1):52-6. Available from: http://www.nih.go.jp/JJID/65/52.pdf
Type
1.
Yang Han X, Sizer KC, Tan H-H. Identification of the leprosy agent Mycobacterium lepromatosis in Singapore. Journal of drugs in dermatology : JDD. 2012;11(2):168-72.
Type
1.
Carvalho K, Bruno F, Snyder-Cappione J, Maeda S, Tomimori J, Xavier M, et al. Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients. Immunology. 2012;136(1):96-102.
Type
1.
Montenegro RMN, Zandonade E, Molina MDCB, Diniz LM. Reactional state and nutritional profile among leprosy patients in the primary health care system, Greater Vitória, Espírito Santo State, Brazil. Cadernos de saude publica [Internet]. 2012;28(1):31-8. Available from: http://www.scielosp.org/pdf/csp/v28n1/04.pdf
Type
1.
Karamanou M, Kyriakis K, Poulakou-Rebelakou E, Androutsos G. [Leprosy in Byzantium]. Presse medicale (Paris, France : 1983). 2012;41(12 Pt 1):1290-3.
Type
1.
Györkö A. La lepra en el Archipielago Canario : (datos históricos y su distribución geográfica) : trabajo presentado al X Congreso internacional de dermatologia reunido en la ciudad de Londres entre los dias 21 y 26 de Julio de 1952. Las Palmas; 1952.
Type
1.
Directorate of Health Services, Govt. of Delhi. Leprosy status in National Capital Territory of Delhi : 2001 - 2002. India: Directorate of Health Services, Govt. of Delhi; 2002.
Type
1.
Holen Ø. [Leprosy is still a major health problem]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 2011;131(24):2444.
Type
1.
Liu P, Wheelwright M, Teles R, Komisopoulou E, Edfeldt K, Ferguson B, et al. MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nature medicine. 2012;18(2):267-73.
Type
1.
Singh, Gaur, Mittal, Biswas, Das, Girdhar, et al. Absence of nucleotide-binding oligomerization domain-containing protein 2 variants in patients with leprosy and tuberculosis. International journal of immunogenetics. 2012;39(4):353-6.